Related Experiment Videos
Effects of subconjunctivally injected antineoplastic agents on three models of corneal inflammation
Abstract:
Three models of corneal inflammation--acute toxic keratitis, phlyctenular keratitis and corneal graft rejection--were induced in rabbits and treated with subconjunctival injections of antineoplastic agents (methotrexate, cytosine arabinoside, 5-fluorouracil and 6-mercaptopurine) and Solu-Medrol (methylprednisolone sodium succinate). The inflammations responded to the drugs to various degrees when compared with the response in control animals treated with saline. Cytosine arabinoside effected a slight decrease in the clinical features of acute toxic keratitis, methotrexate was superior in decreasing inflammation and neovascularization in phlyctenular keratitis, and Solu-Medrol appeared to be the most useful in the treatment of graft rejection. When injected repeatedly, 5-fluorouracil tended to have significant toxicity in the presence of inflammation.
Insights
Antineoplastic agents and Solu-Medrol were tested on rabbit corneal inflammation models. Methotrexate and Solu-Medrol showed promise for specific inflammatory conditions, while 5-fluorouracil exhibited toxicity.
Area of Science:
- Ophthalmology
- Pharmacology
- Immunology
Background:
- Corneal inflammation presents significant challenges in ocular health.
- Various antineoplastic agents and corticosteroids are explored for their therapeutic potential.
Purpose of the Study:
- To evaluate the efficacy of subconjunctival antineoplastic agents and Solu-Medrol in treating induced corneal inflammation models in rabbits.
- To compare the therapeutic effects of methotrexate, cytosine arabinoside, 5-fluorouracil, 6-mercaptopurine, and methylprednisolone sodium succinate.
Main Methods:
- Induction of three distinct corneal inflammation models in rabbits: acute toxic keratitis, phlyctenular keratitis, and corneal graft rejection.
- Treatment administered via subconjunctival injections of selected antineoplastic agents and Solu-Medrol.
- Comparative analysis of treatment outcomes against saline-treated control groups.
Main Results:
- Cytosine arabinoside demonstrated a modest reduction in acute toxic keratitis symptoms.
- Methotrexate proved effective in reducing inflammation and neovascularization in phlyctenular keratitis.
- Solu-Medrol (methylprednisolone sodium succinate) was most beneficial for corneal graft rejection.
- Repeated administration of 5-fluorouracil led to notable toxicity in inflamed corneas.
Conclusions:
- Specific antineoplastic agents and Solu-Medrol exhibit differential efficacy in treating various forms of experimental corneal inflammation.
- Methotrexate and Solu-Medrol show potential as targeted therapies for specific corneal inflammatory conditions.
- Careful consideration of drug toxicity, particularly with 5-fluorouracil, is crucial in managing ocular inflammation.